Patexia Research

Case number 1:22-cv-00083

Lawsuits

Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. > Summary

Court Case Number 1:22-cv-00083

Filing Date Jan 21, 2022

Termination Date Oct 3, 2022

Court Delaware District Court

Status Judgment - Judgment on Consent

JudgesLeonard P. Stark, Richard G. Andrews

Plaintiff

Defendant

Teva Pharmaceuticals

Plaintiff Attorneys

12

Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English

Novartis
Attorney Name: Daniel M. Silver
McCarter & English

Novartis
Attorney Name: Nicholas N. Kallas
Venable

Novartis
Attorney Name: Christopher E. Loh
Venable

Novartis
Attorney Name: Christina A. Schwarz
Venable

Novartis
Attorney Name: Jared L. Stringham
Venable

Novartis
Attorney Name: Alexandra M. Joyce

Novartis
Attorney Name: Nicholas N. Kallas

Novartis
Attorney Name: Christopher E. Loh

Novartis
Attorney Name: Christina A. Schwarz

Novartis
Attorney Name: Daniel M. Silver

Novartis
Attorney Name: Jared L. Stringham

Defendant Attorneys

4

Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP

Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen

Teva Pharmaceuticals
Attorney Name: Mark C. McLennan

Teva Pharmaceuticals
Attorney Name: Jeanna M. Wacker

Counter Defendant

12

Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English

Novartis
Attorney Name: Nicholas N. Kallas
Venable

Novartis
Attorney Name: Christopher E. Loh
Venable

Novartis
Attorney Name: Christina A. Schwarz
Venable

Novartis
Attorney Name: Daniel M. Silver
McCarter & English

Novartis
Attorney Name: Jared L. Stringham
Venable

Novartis
Attorney Name: Alexandra M. Joyce

Novartis
Attorney Name: Nicholas N. Kallas

Novartis
Attorney Name: Christopher E. Loh

Novartis
Attorney Name: Christina A. Schwarz

Novartis
Attorney Name: Daniel M. Silver

Novartis
Attorney Name: Jared L. Stringham

Counter Claimant

2

Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP

Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
11058667	Sacubitril-valsartan dosage regimen for treating heart failure	Jul 13, 2021